Recap: Medifast Q1 Earnings

Medifast MED reported its Q1 earnings results on Monday, May 2, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Medifast beat estimated earnings by 0.56%, reporting an EPS of $3.59 versus an estimate of $3.57.

Revenue was up $76.93 million from the same period last year.

Last quarter the company beat on EPS by $0.26 which was followed by a 2.0% drop in the share price the next day.

Here's a look at Medifast's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	2.65	3.08	3.31	2.73
EPS Actual	2.91	3.56	3.96	3.46
Revenue Estimate	375.79M	403.76M	358.45M	278.89M
Revenue Actual	377.83M	413.39M	394.19M	340.67M

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Medifast management provided guidance for FY 2022, expecting earnings between $14.6 and $16.05 per share.

To track all earnings releases for Medifast visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar